An interventional study of Thoracic Interfascial Plane Block and Erector Spinae Plane Block in Postoperative Pain Following Modified Radical Mastectomy for Breast Cancer, sponsored by Safie ramez tewfeik abd el moneim. Completed at 1 site in Egypt. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Safie ramez tewfeik abd el moneim · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 248 studies in Breast Neoplasms with a site in Egypt — 58 open to participants now, 68 under way, 5 of them phase 3. Breast Neoplasms · Egypt.
Among the 248 studies in Breast Neoplasms with a site in Egypt, this one is the 27th largest by enrollment of the 183 interventional ones that give a count, is one of 31 that started in 2024, is one of 85 with no phase, and was the 180th registered.
14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.
Browse Breast Neoplasms studies →58 of the 248 studies in Breast Neoplasms with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 65–75 · Women only
National Cancer Institute, Egypt · Sites in Egypt
Ages 18–65 · Women only
Adly A Adam · Sites in Egypt
Ages 40–50 · Women only
Sohag University · Sites in Egypt
Ages 18–80
Alexandria University · Sites in Egypt
Ages 18–70 · Women only
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.
This study: 21 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
248 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 46 · Phase 3 47 · Phase 4 11
First in 1997; this study’s year is marked. 31 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is above the median of 72 across 10,921 interventional studies indexed under Breast Neoplasms.
Median enrollment 70 across the 183 interventional studies, 100 across the 63 observational. Of the 131 that completed or were terminated, 20 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 248 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Safie ramez tewfeik abd el moneim as lead sponsor.
Safie ramez tewfeik abd el moneim has 1 study filed under Breast Neoplasms — fewer than ten, so there is no comparison to draw.
17 of the studies in Breast Neoplasms with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06596122Abdelrahman MahmoudVitamin D Supplementation in Breast Cancer Patients | 2026-11-30 |
| NCT07095569National Cancer Institute, EgyptShoulder Denervation for Post Mastectomy Irradiation Shoulder Pain | 2026-12-01 |
| NCT07650305National Cancer Institute, EgyptBilevel Erector Spinae Plane Block Versus Pectoserratus Block for Analgesia in Modified Radical Mastectomy | 2026-12-01 |
| NCT07894133Adly A AdamGait Parameters in Breast Cancer Receiving Chemotherapy Patients | 2026-12-01 |
| NCT01101425European Organisation for Research and Treatment of Cancer - EORTCMale Breast Cancer: Understanding the Biology for Improved Patient Care | 2026-12-31 |
Add all 17 to your calendar (.ics) → With an account.
Among the 248 studies in Breast Neoplasms with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study compares two methods of local pain control in patients undergoing Modified Radical Mastectomy, a common surgery for breast cancer( tumor in the breast) treatment. It aims to determine which method, the Thoracic Interfascial Plane Block or the Erector Spinae Plane Block, provides better pain relief after surgery, reduces side effects,decrease the incidence of persistent pain,improve quality of life and increases patient satisfaction.
Why This Study Is Important:
Breast cancer surgery can cause significant pain, and managing this pain is important for a quick recovery. Currently, pain is often managed with opioids, which can cause side effects like nausea and drowsiness. investigators want to find a method that controls pain effectively with fewer side effects, helping patients recover faster and feel better.
Who Can Take Part:
Women aged 21 and older who are scheduled for a Modified Radical Mastectomy at Ain Shams University hospitals can participate in this study.
What Will Happen During the Study:
Participants will be randomly assigned to receive either the Thoracic Interfascial Plane Block or the Erector Spinae Plane Block before surgery.
Pain levels will be measured using a numerical pain score from 1 to 10. Researchers will track the amount of pain medication needed, the time it takes to feel pain relief, and any side effects.
Other factors such as time to start walking again, and overall satisfaction with pain control will also be recorded.long term outcomes such as Persistent pain, Brief Pain Inventory interference, DN4-interview score, analgesic use and quality of life at 3 and 6 months.
What investigators hope to Learn:
Investigators hope to find out which nerve block provides better pain relief after surgery. By comparing TIPB and ESPB, with the aim to identify the method that:
Requires less additional pain medication Has fewer side effects Improves sleep quality and overall recovery Increases patient satisfaction
Significance:
This study could lead to better pain management strategies for breast cancer surgery, reducing the need for opioids and enhancing patient recovery and comfort, and improving long term satisfaction and quality of life.
Participation:
Participants will be monitored closely during and after the procedure to ensure their safety and well-being. The results of this study could help improve pain management for future patients undergoing similar surgeries.
This study is a randomized, double-blinded clinical trial comparing the efficacy of two ultrasound-guided nerve blocks for postoperative pain management in patients undergoing Modified Radical Mastectomy (MRM). The two techniques under investigation are the Thoracic Interfascial Plane Block (TIPB) and the Erector Spinae Plane Block (ESPB). Both nerve blocks are administered to provide targeted pain relief by numbing specific nerves involved in the surgical area.
Methodology:
Participants will be randomly assigned to one of two groups to receive either TIPB or ESPB. The randomization will ensure unbiased distribution of participants across both groups. The nerve blocks will be administered preoperatively under ultrasound guidance to ensure accurate placement and effectiveness.
Assessments and Measurements:
Pain levels will be assessed using the Visual Analog Scale (VAS) at multiple time points postoperatively, including at rest and during movement. The primary outcome measure is the total amount of rescue pain medication required within the first 48 hours after surgery. Secondary outcomes include the time to first rescue analgesic, intraoperative fentanyl consumption, hemodynamic parameters, sleep quality, time to first ambulation, VAS scores for pain and nausea, and overall patient satisfaction. Persistent pain, Brief Pain Inventory interference, DN4-interview score, analgesic use and quality of life will be assessed by blinded interview at 3 and 6 months
Safety and Monitoring:
Participants will be monitored for adverse events, including complications related to the nerve block techniques. Hemodynamic parameters, such as blood pressure and heart rate, will be closely observed during the perioperative period to ensure patient safety.
Significance:
The findings from this study aim to identify a short and long term superior pain management strategy that minimizes opioid consumption, reduces side effects, and enhances recovery and patient satisfaction following MRM. If successful, the results could inform clinical practice and improve postoperative care for breast cancer patients.
This study is conducted at Ain Shams University hospitals and adheres to ethical guidelines to ensure the safety and well-being of all participants.
The criteria were revised on the registry on Oct 16, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
the Thoracic Interfascial Plane Block, which includes Pecto-Intercostal Fascial Plane Block and Serratus Intercostal Fascial Plane Block, is a peripheral nerve block that targets the intercostal nerve branches scattered throughout the chest and axilla
Procedure: Thoracic Interfascial Plane Block
Erector Spinae Plane Block (ESPB) is an anesthesia technique for providing effective analgesia during and after breast and abdominal surgery
Procedure: Erector Spinae Plane Block
The Thoracic Interfascial Plane Block (TIPB) is a regional anesthesia technique used to manage postoperative pain, particularly in thoracic and breast surgeries. This block involves the injection of a local anesthetic into the fascial plane between the thoracic muscles, targeting the nerves that supply the chest wall and upper abdominal area. It includes Pecto-Intercostal Fascial Plane Block (PIFB) and Serratus Intercostal Fascial Plane Block (SIFB).
Also known as: Thoracic Nerve Block, TIPB
The Erector Spinae Plane Block (ESPB) is a regional anesthesia technique used to manage pain, particularly in thoracic and abdominal surgeries. This block involves the injection of a local anesthetic into the plane between the erector spinae muscle and the transverse processes of the vertebrae.
Also known as: ESPB
Total amount of rescue pain medication required within the first 48 hours after surgery
Researchers will report the total amount of analgesia used in the first 48 hours after surgery
Time frame: 48 hours
Time to first rescue analgesia'
The time at which the first analgesia is adminstered after surgery
Time frame: 48 hours
Total intraoperative fentanyl consumption
The total intraoperative consumption of fentanyl
Time frame: Total intraoperative time of surgery
Time for the first ambulation
The time at which the patient will be first be able to ambulate from bed.
Time frame: 48 hours
VAS score for pain
The postoperative pain using The Visual Analogue Scale (VAS) from 0 to 10, with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be).
Time frame: 48 hours
VAS score for nausea
nausea during the postoperative period using Visual Analogue Scale (VAS) with two endpoints representing 0 ('no nausea') and 10 ('nausea as bad as it could be')
Time frame: 48 hours
Patient Satisfaction score
(five-point Likert scale) where (1 = extremely dissatisfied to 5 = extremely satisfied) to measure postoperative patient satisfaction.
Time frame: 48 hours
presence of persistent pain
pain in the operated breast, chest wall, axilla or ipsilateral arm that had been present since surgery and was not explained by local recurrence, infection or another identifiable cause on a 0-10 numerical rating scale
Time frame: 3 months and 6 months
Pain interference
The seven interference items of the Brief Pain Inventory (general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life; each scored 0-10) were recorded, and the interference score was calculated as their mean
Time frame: 3 months and 6 months
Neuropathic symptoms
Douleur Neuropathique 4 questionnaire (DN4-interview; range 0-7), a score of 3 or more indicated neuropathic pain
Time frame: 3 and 6 months
Analgesic use and pain-clinic attendance
Patients were asked which medicines they were taking for surgical-site pain and at what daily dose and number of visits to pain-management clinic which then confirmed by hospital registry ,clinic and pharmacy records
Time frame: 3 and 6 months
Patient Global Impression of Change
recorded on a seven-point scale from 1 (very much improved) to 7 (very much worse); scores of 1 or 2 were considered a clinically important improvement.
Time frame: 3 and 6 months
Health-related quality of life
EORTC QLQ-C30 and its breast cancer module (QLQ-BR23) validated Arabic versions
Time frame: 3 and 6 months
Plan to share: No
Ran from Nov 2024 to primary completion in Dec 2025, 13 months.
Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's 13 months is below that.
Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Mar 2025 → Dec 2025 and completion Mar 2025 → Jun 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.